All
Roche to appeal $2.62 million judgment in Accutane case
July 1st 2007Hoffmann-LaRoche, Inc., the makers of Accutane, will appeal a multimillion dollar jury verdict awarded to a man who said his irritable bowel disease was caused by the medication. Aside for the financial considerations, physicians are concerned that the case will make it more difficult for suitable patients to use a very valuable medication.
Allergan: Juvederm needle fix in the works
July 1st 2007Juvéderm is a useful product and fills a void, but problems with needle separation - whether due to operator error or product/syringe design - has spooked some practitioners. Allergan is working to resolve the issue and in the meantime, offers tips for injection technique that can help alleviate the possibility of needle and syringe separation.
Study recommends malathion as first-line treatment for head lice
June 5th 2007New York - A new study suggests that malathion should be used as a first-line treatment of head lice infestation in children and that therapy for head lice should be based on the life cycle of the lice, drug resistance and safety considerations, Medscape news source reports.
Trial results shows TA-65 leads to improved skin condition among older people
June 5th 2007New York - Telomerase Activation Sciences Inc., based here, has announced the results of its Pivotal 2005 Anti-Aging Trial of TA-65, the first human trial to show measurable and positive anti-aging benefits - including improvement in skin condition - from a telomerase activator, PRNewswire reports.
FDA approves Altabax for treatment of impetigo
June 5th 2007Washington - The Food and Drug Administration (FDA) has approved GlaxoSmithKline's antibacterial Altabax for the topical treatment of impetigo due to susceptible strains of Staphylococcus aureus or Streptococcus pyogenes, the two most common types of bacteria in this kind of infection, reports News-Medical.net.
Review: Sunscreens lag behind protective measures in minimizing skin cancer risks
June 5th 2007Zurich, Switzerland - Compared with using sunscreens, limiting of exposure to the sun and wearing sun-protective clothes are the most effective ways to reduce skin-cancer risks, reports Medscape in covering a review by a Swiss team published recently in the online issue of The Lancet.
When skin goes from normal to super-sensitive
June 1st 2007What's happening to your skin? Once so easygoing and "normal," it now seems to react to whatever you put on it. Sometimes it stings, sometimes it burns. It looks oddly red after washing - and the expensive new creams and lotions you've bought lately only make things worse.
Itching to get a good night's sleep
June 1st 2007You've just slipped between your cool, inviting sheets when it happens. You're lying there, calmly trying to fall asleep, when you become acutely aware of your body - and that every inch is itching or prickling. You scratch one spot, then another, then another - but it's as if your skin has a mind of its own.